Description

Metformin Tablets

Metformin Hydrochloride Tablets USP / BP / IP (500 mg / 850 mg / 1000 mg / SR Formats)

First-Line Biguanide Oral Hypoglycemic & Insulin Sensitizer

Healthy Life Pharma Private Limited, together with our specialized global export and marketing division Healthy Inc, is a leading Indian manufacturer, CDMO partner, and wholesale exporter of advanced endocrinology, metabolic health, and chronic disease therapeutics. We manufacture an internationally validated, massive-scale range of Metformin Hydrochloride Formulations within our state-of-the-art, WHO–GMP certified solid dosage manufacturing installations.

Serving as the fundamental clinical anchor for global diabetes management, this essential public health commodity represents a high-velocity strategic export to national health ministries, public hospital networks, state insurance purchasing cooperatives, and international digital B2B marketplaces across the CIS region, Sub-Saharan Africa, LATAM, and South-East Asia.

Product Overview

This formulation operates as a “Hepatic Glucose Production Brake & Cellular Insulin Sensitizer.” It ensures systemic glycemic control and protects long-term vascular health by dropping circulating blood sugar levels without over-stimulating the pancreas or triggering dangerous hypoglycemic crashes.

• Mechanism 1 (Hepatic Gluconeogenesis Suppression): Metformin enters hepatocytes and physically targets the mitochondria, where it chemically activates Adenosine Monophosphate-Activated Protein Kinase (AMPK). This molecular activation halts gluconeogenesis (the liver’s production of new glucose) and shuts down glycogenolysis, cutting off the primary source of excessive fasting blood sugar.

• Mechanism 2 (Peripheral Insulin Sensitization): Concurrently, it increases the physical sensitivity of peripheral tissue cells (most notably skeletal muscle and adipose tissue) to endogenous insulin. This triggers a rapid upregulation and translocation of GLUT-4 glucose transporter proteins to cell membranes, multiplying peripheral glucose uptake and utilization.

• Mechanism 3 (Intestinal Absorption Restraint): It displays a localized regulatory action inside the gastrointestinal tract, slowing down the physical absorption rate of dietary glucose across the intestinal mucosal wall, flattening postprandial (post-meal) blood sugar spikes.

Product Composition & Available Specifications

We supply Metformin Hydrochloride across the full spectrum of compendial strengths and advanced kinetic delivery platforms to optimize patient compliance and reduce gastrointestinal side effects.

Technical & Logistics Specifications

• HS Code: 3004.90.71 (Medicaments acting on the endocrine system / Antidiabetics / Biguanides) or 3004.90.99 (General Category)

• CAS Number: 1115-70-4 (Metformin Hydrochloride) / 657-24-9 (Metformin Base)

• Dosage Form Options: Immediate-Release Film-Coated Tablets, or Sustained-Release (SR) Polymeric Retard Tablets.

• Packaging Configurations:

  • Blister Formats: 10 / 14 / 15 / 30 Tablets per Blister Strip packed in high-barrier Alu-Alu (Cold-Form Foil) or heavy moisture-shield Blisters.

  • Institutional Tenders: Bulk packs of 100 / 500 / 1000 Tablets per induction-sealed HDPE Bottle featuring custom-integrated internal desiccant inserts to optimize shipping cube efficiency for national ministries. Metformin is highly hygroscopic; our tropicalized packaging parameters guarantee a full 36-month shelf life in hot, humid Zone IVb export environments.

High-Capacity Solid Compression Engineering & Quality Attributes

                 [ MICRONIZED HIGH-MASS METFORMIN API ]
                                   │
                                   ▼
               [ HIGH-SHEAR WET GRANULATION ISO-BLOCK ]
                                   │ (Relative humidity held strictly below 35%)
                                   ▼
               [ HEAVY ROTARY PRESS CONTINUOUS COMPRESSION ]
                                   │ ( Calibrated radial hardness 7.0-12.0 kp )
         ┌─────────────────────────┴─────────────────────────┐
         ▼                                                   ▼
 [ ZERO-SEGREGATION MATRIX ]                     [ ADVANCED HYDROGEL RELEASE ]
 Flawless Weight Uniformity (<2% CV)              Strict SR Dissolution Kinetics

• High-Mass Wet Granulation Engineering: Metformin requires exceptionally high active drug load percentages per tablet (up to 1000 mg of pure API), making the powder naturally prone to compressibility defects, capping, and die-sticking. We deploy Advanced High-Shear Fluid-Bed Granulators, chemically binding the active particles with specialized binders into dense, free-flowing granules. This ensures perfect weight uniformity during rapid compression.

• Heavy-Duty Rotary Press Execution: To satisfy heavy institutional tender contracts running into millions of units, we operate heavy-duty automated rotary presses equipped with Forced-Feeder Die Matrix Modules and Online Multi-Point Electronic Weight Checkers, ensuring flawless content uniformity.

• Sustained-Release Hydrogel Calibration: Our SR configurations utilize a specialized Gellan Gum and Hydroxypropyl Methylcellulose (HPMC) Hydrophilic Matrix. Upon entering the stomach, the polymer hydrates into a dense gel layer, forcing the active Metformin molecules to diffuse at a strictly linear kinetic rate over 12 to 24 hours, safely reducing peak mucosal exposure.

Primary Indications

• Endocrinology & Diabetology: First-line medical management of Type 2 Diabetes Mellitus, particularly in overweight and obese patient profiles, as monotherapy or as an anchor in combination with sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, or insulin.

• Metabolic Gynecology: Off-label carefully monitored management of insulin resistance associated with Polycystic Ovary Syndrome (PCOS) to restore regular ovulatory cycles.

Usage Instructions

• The Post-Meal Administration Rule: Take immediate-release formats orally with or immediately after a substantial meal (breakfast and dinner). Administering the drug alongside food is physically critical, as it dampens initial transient gastrointestinal side effects (bloating, flatulence, abdominal cramping).

• The SR Integrity Mandate: For the 500 mg / 1000 mg SR configurations, the tablet must be swallowed physically whole with water. Never chew, crush, or split the sustained-release matrix. Mechanically fracturing the core destroys the hydrophilic gel barrier, chemically causing immediate dumping of the entire high-dose payload (dose-dumping), causing immediate abdominal distress and therapeutic kinetic failure.

• The eGFR Renal Clearance Check: Metformin is excreted completely unchanged via renal filtration paths. It is clinically mandatory to check baseline and periodic Estimated Glomerular Filtration Rate (eGFR) scores. Doses must be scaled down if eGFR falls below 45 mL/min/1.73m², and the drug must be completely discontinued if eGFR drops below 30 mL/min/1.73m².

Safety Warning: FIRST-LINE BIGUANIDE ORAL HYPOGLYCEMIC. For Physician and Endocrinologist Supervision Only. The Lactic Acidosis Warning: Metformin carries a rare but serious chemical risk of inducing mitochondrial accumulation, physically resulting in Lactic Acidosis, which can be life-threatening if it accumulates during acute renal failure. Discontinue therapy immediately during episodes of severe dehydration, systemic shock, or acute myocardial infarction. The Iodinated Contrast Media Rule: Physically suspend Metformin administration at least 48 hours prior to and 48 hours following any diagnostic procedure utilizing intravenous iodinated contrast media to eliminate the risk of contrast-induced acute renal failure causing drug accumulation. Contraindications: Absolute contraindications in patients with severe renal failure ($\text{eGFR} < 30\,\text{mL/min/1.73m}^2$), acute or chronic metabolic acidosis, diabetic ketoacidosis, or known hypersensitivity to biguanide structures.

Global CDMO Services & Wholesale Tender Supply

Healthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export supply for the entire Metformin Hydrochloride portfolio. Because this molecule faces zero controlled-substance dual-licensing regulatory hurdles, our high-capacity lines can rapidly manufacture, release, and ship multi-container shipping loads. We handle all mandatory documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for seamless customs entry and rapid national registration.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Call: +91 7710003340

• Endocrine Registry Email: info@healthyinc.co.in